Coagulopathy in COVID-19: Manifestations and management
Cleve Clin J Med
; 87(8):461-468, 2020.
Article
in English
| MEDLINE | ID: covidwho-721560
ABSTRACT
Severe COVID-19 illness is associated with intense inflammation, leading to high rates of thrombotic complications that increase morbidity and mortality. Markedly elevated levels of D-dimer with normal fibrinogen levels are the hallmark laboratory findings of severe COVID-19- associated coagulopathy. Prophylaxis against venous thromboembolism is paramount for all hospitalized patients, with more aggressive prophylaxis and screening recommended for patients with D-dimer levels above 3.0 µg/mL. Point-of-care ultrasonography is the imaging method of choice for patients at high risk, as it entails minimal risk of exposing providers to the virus.
Full text:
Available
Collection:
Databases of international organizations
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Cleve Clin J Med
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS